

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 4.38656316 |
| 2 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 4.29687617 |
| 3 | protein retention in ER lumen (GO:0006621) | 4.23954644 |
| 4 | skin morphogenesis (GO:0043589) | 4.08245551 |
| 5 | COPI coating of Golgi vesicle (GO:0048205) | 3.96973692 |
| 6 | Golgi transport vesicle coating (GO:0048200) | 3.96973692 |
| 7 | fibrinolysis (GO:0042730) | 3.85880656 |
| 8 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.80600357 |
| 9 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.72544715 |
| 10 | L-phenylalanine metabolic process (GO:0006558) | 3.72544715 |
| 11 | protein maturation by protein folding (GO:0022417) | 3.59084040 |
| 12 | negative regulation of fibrinolysis (GO:0051918) | 3.40411998 |
| 13 | cellular response to follicle-stimulating hormone stimulus (GO:0071372) | 3.34529642 |
| 14 | type B pancreatic cell proliferation (GO:0044342) | 3.31756007 |
| 15 | cellular response to cadmium ion (GO:0071276) | 3.22597542 |
| 16 | protein carboxylation (GO:0018214) | 3.18549383 |
| 17 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.18549383 |
| 18 | regulation of fibrinolysis (GO:0051917) | 3.10905431 |
| 19 | urea metabolic process (GO:0019627) | 3.10222255 |
| 20 | regulation of plasminogen activation (GO:0010755) | 3.08357966 |
| 21 | cell adhesion mediated by integrin (GO:0033627) | 3.05477017 |
| 22 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.03812201 |
| 23 | regulation of integrin-mediated signaling pathway (GO:2001044) | 3.02191969 |
| 24 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.99064240 |
| 25 | L-phenylalanine catabolic process (GO:0006559) | 2.99064240 |
| 26 | urea cycle (GO:0000050) | 2.93456107 |
| 27 | regulation of mitotic spindle organization (GO:0060236) | 2.93056464 |
| 28 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.92082299 |
| 29 | desmosome organization (GO:0002934) | 2.89208455 |
| 30 | lipopolysaccharide biosynthetic process (GO:0009103) | 2.88186830 |
| 31 | bile acid biosynthetic process (GO:0006699) | 2.85375262 |
| 32 | glomerular visceral epithelial cell development (GO:0072015) | 2.85203100 |
| 33 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.82510156 |
| 34 | atrioventricular valve morphogenesis (GO:0003181) | 2.81420239 |
| 35 | negative regulation of coagulation (GO:0050819) | 2.81299641 |
| 36 | glyoxylate metabolic process (GO:0046487) | 2.80592704 |
| 37 | phosphate ion transmembrane transport (GO:0035435) | 2.79903447 |
| 38 | chondrocyte proliferation (GO:0035988) | 2.76281482 |
| 39 | carnitine metabolic process (GO:0009437) | 2.76258809 |
| 40 | cellular response to zinc ion (GO:0071294) | 2.74071701 |
| 41 | kidney mesenchyme development (GO:0072074) | 2.74010952 |
| 42 | tricarboxylic acid cycle (GO:0006099) | 2.73230481 |
| 43 | endothelial cell morphogenesis (GO:0001886) | 2.72610827 |
| 44 | membrane raft organization (GO:0031579) | 2.71128444 |
| 45 | amino-acid betaine metabolic process (GO:0006577) | 2.70960044 |
| 46 | galactose catabolic process (GO:0019388) | 2.70051235 |
| 47 | glomerular basement membrane development (GO:0032836) | 2.67334319 |
| 48 | NADH metabolic process (GO:0006734) | 2.67260836 |
| 49 | negative regulation of lipase activity (GO:0060192) | 2.65740600 |
| 50 | metanephric mesenchyme development (GO:0072075) | 2.65011576 |
| 51 | basement membrane organization (GO:0071711) | 2.64927697 |
| 52 | endocardial cushion development (GO:0003197) | 2.63722063 |
| 53 | protein hydroxylation (GO:0018126) | 2.57200776 |
| 54 | nitrogen cycle metabolic process (GO:0071941) | 2.55536909 |
| 55 | negative regulation of hemostasis (GO:1900047) | 2.54844102 |
| 56 | negative regulation of blood coagulation (GO:0030195) | 2.54844102 |
| 57 | mitotic nuclear envelope reassembly (GO:0007084) | 2.53653995 |
| 58 | nuclear envelope reassembly (GO:0031468) | 2.53653995 |
| 59 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 2.53532350 |
| 60 | biotin metabolic process (GO:0006768) | 2.52661795 |
| 61 | positive regulation of extracellular matrix organization (GO:1903055) | 2.52020085 |
| 62 | cellular response to gonadotropin stimulus (GO:0071371) | 2.51605669 |
| 63 | peptidyl-proline hydroxylation (GO:0019511) | 2.48420708 |
| 64 | actin filament depolymerization (GO:0030042) | 2.46865624 |
| 65 | 4-hydroxyproline metabolic process (GO:0019471) | 2.46152928 |
| 66 | proteasome assembly (GO:0043248) | 2.43382662 |
| 67 | positive regulation of male gonad development (GO:2000020) | 2.42770916 |
| 68 | regulation of protein activation cascade (GO:2000257) | 2.40668631 |
| 69 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.40550187 |
| 70 | negative regulation of wound healing (GO:0061045) | 2.39927406 |
| 71 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.38351617 |
| 72 | protein heterotetramerization (GO:0051290) | 2.37500956 |
| 73 | glomerular epithelial cell development (GO:0072310) | 2.37460568 |
| 74 | regulation of cholesterol homeostasis (GO:2000188) | 2.36881389 |
| 75 | C21-steroid hormone biosynthetic process (GO:0006700) | 2.35572702 |
| 76 | extracellular fibril organization (GO:0043206) | 2.35413872 |
| 77 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.34892486 |
| 78 | gap junction assembly (GO:0016264) | 2.34219393 |
| 79 | response to follicle-stimulating hormone (GO:0032354) | 2.34058233 |
| 80 | xenobiotic catabolic process (GO:0042178) | 2.33870599 |
| 81 | branching involved in salivary gland morphogenesis (GO:0060445) | 2.32789038 |
| 82 | purine nucleotide transport (GO:0015865) | 2.32242992 |
| 83 | regulation of metalloenzyme activity (GO:0048552) | 2.30869268 |
| 84 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.28938683 |
| 85 | diaphragm development (GO:0060539) | 2.27047360 |
| 86 | positive regulation of actin filament depolymerization (GO:0030836) | 2.26746737 |
| 87 | midgut development (GO:0007494) | 2.25115159 |
| 88 | regulation of bile acid biosynthetic process (GO:0070857) | 2.24490299 |
| 89 | regulation of cardioblast differentiation (GO:0051890) | 2.23713714 |
| 90 | negative regulation of complement activation (GO:0045916) | 2.23180769 |
| 91 | regulation of complement activation (GO:0030449) | 2.21407410 |
| 92 | bile acid metabolic process (GO:0008206) | 2.21130727 |
| 93 | phosphate ion transport (GO:0006817) | 2.21045910 |
| 94 | barbed-end actin filament capping (GO:0051016) | 2.18900228 |
| 95 | regulation of water loss via skin (GO:0033561) | 2.18879060 |
| 96 | galactose metabolic process (GO:0006012) | 2.18673416 |
| 97 | sulfur amino acid catabolic process (GO:0000098) | 2.18335928 |
| 98 | cofactor catabolic process (GO:0051187) | 2.18089087 |
| 99 | muscle cell migration (GO:0014812) | 2.17609535 |
| 100 | COPII vesicle coating (GO:0048208) | 2.16808067 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 4.40768575 |
| 2 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 4.07870441 |
| 3 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.94564664 |
| 4 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.60552641 |
| 5 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.37729220 |
| 6 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.91514504 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.78010589 |
| 8 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 2.76227612 |
| 9 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.65653195 |
| 10 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.56519417 |
| 11 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.47672942 |
| 12 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.34823863 |
| 13 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.32326660 |
| 14 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.22641371 |
| 15 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.11477276 |
| 16 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.05128948 |
| 17 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.96788617 |
| 18 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.95156150 |
| 19 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.92242849 |
| 20 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.83106322 |
| 21 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.82987110 |
| 22 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.81809273 |
| 23 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.81523808 |
| 24 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.79151951 |
| 25 | ATF3_27146783_Chip-Seq_COLON_Human | 1.76691227 |
| 26 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.74731657 |
| 27 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.74362521 |
| 28 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.74234475 |
| 29 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.74234475 |
| 30 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.71374008 |
| 31 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.70367289 |
| 32 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.69987968 |
| 33 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.63109854 |
| 34 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.60836398 |
| 35 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.58563421 |
| 36 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.57717020 |
| 37 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.57155449 |
| 38 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.55226700 |
| 39 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.54300736 |
| 40 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.53629474 |
| 41 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.49592574 |
| 42 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.43752501 |
| 43 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.41404734 |
| 44 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.40587150 |
| 45 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.39431672 |
| 46 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.39065278 |
| 47 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.38401381 |
| 48 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.37410576 |
| 49 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.37206253 |
| 50 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.35942210 |
| 51 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.33808422 |
| 52 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.33505768 |
| 53 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.32833724 |
| 54 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.32104276 |
| 55 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.30394755 |
| 56 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.29931030 |
| 57 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.29582191 |
| 58 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.28431258 |
| 59 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.27465350 |
| 60 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.23713550 |
| 61 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.23044998 |
| 62 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.21095792 |
| 63 | EOMES_21245162_ChIP-Seq_HESCs_Human | 1.20762355 |
| 64 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.19560390 |
| 65 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.16326082 |
| 66 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.16038666 |
| 67 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.15725888 |
| 68 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.15235209 |
| 69 | CJUN_26792858_Chip-Seq_BT549_Human | 1.14549048 |
| 70 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.14096334 |
| 71 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.13411289 |
| 72 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.12411909 |
| 73 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.11317976 |
| 74 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.09899039 |
| 75 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.06561440 |
| 76 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.06216238 |
| 77 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.06062931 |
| 78 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.06062931 |
| 79 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.06024908 |
| 80 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.05396431 |
| 81 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.03875255 |
| 82 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.03762689 |
| 83 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.02613390 |
| 84 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.00935245 |
| 85 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.00752924 |
| 86 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.98471744 |
| 87 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.97586587 |
| 88 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.97165425 |
| 89 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.95829622 |
| 90 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.95771610 |
| 91 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 0.94815366 |
| 92 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.94384927 |
| 93 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.94354638 |
| 94 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.94108207 |
| 95 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.93611500 |
| 96 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.92770706 |
| 97 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.92109908 |
| 98 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.91254120 |
| 99 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.90810398 |
| 100 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.90737058 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008438_abnormal_cutaneous_collagen | 4.46837523 |
| 2 | MP0003705_abnormal_hypodermis_morpholog | 3.62103786 |
| 3 | MP0004272_abnormal_basement_membrane | 3.02894238 |
| 4 | MP0010030_abnormal_orbit_morphology | 2.97501795 |
| 5 | MP0005360_urolithiasis | 2.84226976 |
| 6 | MP0003950_abnormal_plasma_membrane | 2.69805798 |
| 7 | MP0003566_abnormal_cell_adhesion | 2.62333495 |
| 8 | MP0010234_abnormal_vibrissa_follicle | 2.51013016 |
| 9 | MP0005257_abnormal_intraocular_pressure | 2.49469982 |
| 10 | MP0010368_abnormal_lymphatic_system | 2.46639747 |
| 11 | MP0003941_abnormal_skin_development | 2.44007429 |
| 12 | MP0009780_abnormal_chondrocyte_physiolo | 2.40133424 |
| 13 | MP0002139_abnormal_hepatobiliary_system | 2.36190853 |
| 14 | MP0005275_abnormal_skin_tensile | 2.30078679 |
| 15 | MP0009384_cardiac_valve_regurgitation | 2.28657963 |
| 16 | MP0009697_abnormal_copulation | 2.26225435 |
| 17 | MP0005365_abnormal_bile_salt | 2.22813151 |
| 18 | MP0003806_abnormal_nucleotide_metabolis | 2.10375462 |
| 19 | MP0008875_abnormal_xenobiotic_pharmacok | 1.98198752 |
| 20 | MP0004233_abnormal_muscle_weight | 1.92624276 |
| 21 | MP0005623_abnormal_meninges_morphology | 1.90520451 |
| 22 | MP0005058_abnormal_lysosome_morphology | 1.87153850 |
| 23 | MP0000751_myopathy | 1.86331767 |
| 24 | MP0009053_abnormal_anal_canal | 1.85651181 |
| 25 | MP0005085_abnormal_gallbladder_physiolo | 1.83552420 |
| 26 | MP0001661_extended_life_span | 1.73061141 |
| 27 | MP0000762_abnormal_tongue_morphology | 1.62631951 |
| 28 | MP0003191_abnormal_cellular_cholesterol | 1.61992386 |
| 29 | MP0003868_abnormal_feces_composition | 1.58546227 |
| 30 | MP0005023_abnormal_wound_healing | 1.52865125 |
| 31 | MP0000749_muscle_degeneration | 1.44771399 |
| 32 | MP0002060_abnormal_skin_morphology | 1.44608601 |
| 33 | MP0003186_abnormal_redox_activity | 1.42762101 |
| 34 | MP0003279_aneurysm | 1.37562382 |
| 35 | MP0002295_abnormal_pulmonary_circulatio | 1.35123830 |
| 36 | MP0001849_ear_inflammation | 1.34860684 |
| 37 | MP0004858_abnormal_nervous_system | 1.33556120 |
| 38 | MP0010352_gastrointestinal_tract_polyps | 1.31562735 |
| 39 | MP0002796_impaired_skin_barrier | 1.29800979 |
| 40 | MP0002254_reproductive_system_inflammat | 1.28166506 |
| 41 | MP0003091_abnormal_cell_migration | 1.27871282 |
| 42 | MP0001299_abnormal_eye_distance/ | 1.26195395 |
| 43 | MP0009840_abnormal_foam_cell | 1.25684394 |
| 44 | MP0000767_abnormal_smooth_muscle | 1.23852542 |
| 45 | MP0000003_abnormal_adipose_tissue | 1.21590002 |
| 46 | MP0002877_abnormal_melanocyte_morpholog | 1.20922681 |
| 47 | MP0010386_abnormal_urinary_bladder | 1.20659270 |
| 48 | MP0005330_cardiomyopathy | 1.15716556 |
| 49 | MP0001542_abnormal_bone_strength | 1.15427074 |
| 50 | MP0005197_abnormal_uvea_morphology | 1.14191144 |
| 51 | MP0006138_congestive_heart_failure | 1.11806952 |
| 52 | MP0005501_abnormal_skin_physiology | 1.11595055 |
| 53 | MP0000013_abnormal_adipose_tissue | 1.08787904 |
| 54 | MP0001243_abnormal_dermal_layer | 1.05060003 |
| 55 | MP0005503_abnormal_tendon_morphology | 1.03676223 |
| 56 | MP0000750_abnormal_muscle_regeneration | 0.98638789 |
| 57 | MP0005165_increased_susceptibility_to | 0.97651260 |
| 58 | MP0002896_abnormal_bone_mineralization | 0.95629022 |
| 59 | MP0003315_abnormal_perineum_morphology | 0.95569144 |
| 60 | MP0001346_abnormal_lacrimal_gland | 0.93896489 |
| 61 | MP0001853_heart_inflammation | 0.93409685 |
| 62 | MP0001666_abnormal_nutrient_absorption | 0.93264303 |
| 63 | MP0005332_abnormal_amino_acid | 0.93152283 |
| 64 | MP0001958_emphysema | 0.92333203 |
| 65 | MP0000467_abnormal_esophagus_morphology | 0.91667008 |
| 66 | MP0010329_abnormal_lipoprotein_level | 0.90979574 |
| 67 | MP0005375_adipose_tissue_phenotype | 0.87971612 |
| 68 | MP0001915_intracranial_hemorrhage | 0.87916955 |
| 69 | MP0004185_abnormal_adipocyte_glucose | 0.87664247 |
| 70 | MP0005508_abnormal_skeleton_morphology | 0.87364914 |
| 71 | MP0000639_abnormal_adrenal_gland | 0.86701417 |
| 72 | MP0000733_abnormal_muscle_development | 0.86447702 |
| 73 | MP0000759_abnormal_skeletal_muscle | 0.85557390 |
| 74 | MP0003942_abnormal_urinary_system | 0.85291647 |
| 75 | MP0003453_abnormal_keratinocyte_physiol | 0.85280354 |
| 76 | MP0005670_abnormal_white_adipose | 0.83236806 |
| 77 | MP0005666_abnormal_adipose_tissue | 0.83050567 |
| 78 | MP0003075_altered_response_to | 0.82661982 |
| 79 | MP0010771_integument_phenotype | 0.81471112 |
| 80 | MP0002269_muscular_atrophy | 0.79826077 |
| 81 | MP0003011_delayed_dark_adaptation | 0.75886999 |
| 82 | MP0009250_abnormal_appendicular_skeleto | 0.74570194 |
| 83 | MP0000579_abnormal_nail_morphology | 0.74449297 |
| 84 | MP0003115_abnormal_respiratory_system | 0.72702781 |
| 85 | MP0005595_abnormal_vascular_smooth | 0.72535891 |
| 86 | MP0004087_abnormal_muscle_fiber | 0.72299004 |
| 87 | MP0005451_abnormal_body_composition | 0.72100424 |
| 88 | MP0001879_abnormal_lymphatic_vessel | 0.71989282 |
| 89 | MP0002168_other_aberrant_phenotype | 0.71589811 |
| 90 | MP0002972_abnormal_cardiac_muscle | 0.70479157 |
| 91 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.69845147 |
| 92 | MP0000538_abnormal_urinary_bladder | 0.69379941 |
| 93 | MP0001340_abnormal_eyelid_morphology | 0.68123721 |
| 94 | MP0001216_abnormal_epidermal_layer | 0.67276813 |
| 95 | MP0005164_abnormal_response_to | 0.66163104 |
| 96 | MP0002108_abnormal_muscle_morphology | 0.66106308 |
| 97 | MP0002282_abnormal_trachea_morphology | 0.64941400 |
| 98 | MP0000747_muscle_weakness | 0.63553988 |
| 99 | MP0000534_abnormal_ureter_morphology | 0.63361825 |
| 100 | MP0003634_abnormal_glial_cell | 0.62776263 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Premature rupture of membranes (HP:0001788) | 4.80964008 |
| 2 | Vertebral compression fractures (HP:0002953) | 4.27194194 |
| 3 | Protrusio acetabuli (HP:0003179) | 4.04216641 |
| 4 | Deep venous thrombosis (HP:0002625) | 3.38994802 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.24613182 |
| 6 | Vascular calcification (HP:0004934) | 3.10289379 |
| 7 | Abnormality of dentin (HP:0010299) | 3.08740931 |
| 8 | Cardiovascular calcification (HP:0011915) | 3.08410924 |
| 9 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.07639275 |
| 10 | Distal lower limb muscle weakness (HP:0009053) | 3.01599215 |
| 11 | Achilles tendon contracture (HP:0001771) | 3.00095475 |
| 12 | Cholecystitis (HP:0001082) | 2.98975549 |
| 13 | Abnormal gallbladder physiology (HP:0012438) | 2.98975549 |
| 14 | Abnormality of the Achilles tendon (HP:0005109) | 2.91284083 |
| 15 | Short nail (HP:0001799) | 2.83728544 |
| 16 | Upper limb amyotrophy (HP:0009129) | 2.76150298 |
| 17 | Distal upper limb amyotrophy (HP:0007149) | 2.76150298 |
| 18 | Cervical subluxation (HP:0003308) | 2.73458614 |
| 19 | Hypokinesia (HP:0002375) | 2.72172525 |
| 20 | Mesangial abnormality (HP:0001966) | 2.70484110 |
| 21 | Increased serum pyruvate (HP:0003542) | 2.52828668 |
| 22 | Hand muscle atrophy (HP:0009130) | 2.52150015 |
| 23 | Abnormality of glycolysis (HP:0004366) | 2.48605826 |
| 24 | Intrahepatic cholestasis (HP:0001406) | 2.35048238 |
| 25 | Gonadal dysgenesis (HP:0000133) | 2.34301884 |
| 26 | Mitral stenosis (HP:0001718) | 2.34081316 |
| 27 | Prolonged partial thromboplastin time (HP:0003645) | 2.32413719 |
| 28 | Upper motor neuron abnormality (HP:0002127) | 2.23977622 |
| 29 | Hypoplastic left heart (HP:0004383) | 2.21149039 |
| 30 | Ankle contracture (HP:0006466) | 2.19927733 |
| 31 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.19730494 |
| 32 | Osteolytic defects of the hand bones (HP:0009699) | 2.19730494 |
| 33 | Spinal rigidity (HP:0003306) | 2.19130848 |
| 34 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.18609504 |
| 35 | Generalized amyotrophy (HP:0003700) | 2.17066839 |
| 36 | Blue sclerae (HP:0000592) | 2.16593696 |
| 37 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.14986192 |
| 38 | Entropion (HP:0000621) | 2.14312767 |
| 39 | Shallow orbits (HP:0000586) | 2.09076785 |
| 40 | Follicular hyperkeratosis (HP:0007502) | 2.07624134 |
| 41 | Nemaline bodies (HP:0003798) | 2.07291205 |
| 42 | Increased connective tissue (HP:0009025) | 2.05446681 |
| 43 | Type 1 muscle fiber predominance (HP:0003803) | 2.03312793 |
| 44 | Wormian bones (HP:0002645) | 2.00090886 |
| 45 | Mucopolysacchariduria (HP:0008155) | 1.98777057 |
| 46 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.98777057 |
| 47 | Renal duplication (HP:0000075) | 1.97902684 |
| 48 | Distal lower limb amyotrophy (HP:0008944) | 1.97420340 |
| 49 | Trismus (HP:0000211) | 1.97142495 |
| 50 | Acanthosis nigricans (HP:0000956) | 1.96839905 |
| 51 | Elbow flexion contracture (HP:0002987) | 1.93585390 |
| 52 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.92411654 |
| 53 | Abnormality of glycolipid metabolism (HP:0010969) | 1.92334699 |
| 54 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.92334699 |
| 55 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.92334699 |
| 56 | Biconcave vertebral bodies (HP:0004586) | 1.92293823 |
| 57 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.91252144 |
| 58 | Hypoalphalipoproteinemia (HP:0003233) | 1.89749152 |
| 59 | Focal segmental glomerulosclerosis (HP:0000097) | 1.88695916 |
| 60 | Xanthomatosis (HP:0000991) | 1.88567174 |
| 61 | Nuclear cataract (HP:0100018) | 1.87252665 |
| 62 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.86591478 |
| 63 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.86591478 |
| 64 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.86591478 |
| 65 | Glucose intolerance (HP:0000833) | 1.86443299 |
| 66 | Vascular tortuosity (HP:0004948) | 1.86150579 |
| 67 | Bladder diverticulum (HP:0000015) | 1.84416309 |
| 68 | Abnormality of the intrinsic pathway (HP:0010989) | 1.83779051 |
| 69 | Muscle fiber inclusion bodies (HP:0100299) | 1.83407411 |
| 70 | Atrophic scars (HP:0001075) | 1.82128066 |
| 71 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.81851453 |
| 72 | Testicular neoplasm (HP:0010788) | 1.79166492 |
| 73 | Hyperacusis (HP:0010780) | 1.78822789 |
| 74 | Hypoplastic heart (HP:0001961) | 1.78590171 |
| 75 | Glomerulosclerosis (HP:0000096) | 1.78390815 |
| 76 | Arterial tortuosity (HP:0005116) | 1.77014788 |
| 77 | Spinal cord compression (HP:0002176) | 1.76020420 |
| 78 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.75762754 |
| 79 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.75503223 |
| 80 | Right ventricular cardiomyopathy (HP:0011663) | 1.75046985 |
| 81 | Reduced antithrombin III activity (HP:0001976) | 1.74435155 |
| 82 | Sex reversal (HP:0012245) | 1.73329149 |
| 83 | Abnormal sex determination (HP:0012244) | 1.73329149 |
| 84 | Broad metatarsal (HP:0001783) | 1.72781196 |
| 85 | Paraparesis (HP:0002385) | 1.71754888 |
| 86 | Hypolipoproteinemia (HP:0010981) | 1.70448543 |
| 87 | Turricephaly (HP:0000262) | 1.68079537 |
| 88 | Abnormality of the lower motor neuron (HP:0002366) | 1.67195657 |
| 89 | Delayed gross motor development (HP:0002194) | 1.65353632 |
| 90 | Coxa vara (HP:0002812) | 1.64879697 |
| 91 | Abnormality of the vocal cords (HP:0008777) | 1.64859190 |
| 92 | Abnormality of carpal bone ossification (HP:0006257) | 1.64243484 |
| 93 | Decreased subcutaneous fat (HP:0001002) | 1.63314879 |
| 94 | Insomnia (HP:0100785) | 1.63122075 |
| 95 | Fragile skin (HP:0001030) | 1.61990769 |
| 96 | Abnormality of the acetabulum (HP:0003170) | 1.61703278 |
| 97 | Abnormal ventriculo-arterial connection (HP:0011563) | 1.61343215 |
| 98 | Transposition of the great arteries (HP:0001669) | 1.61343215 |
| 99 | Abnormal connection of the cardiac segments (HP:0011545) | 1.61343215 |
| 100 | Abnormal delivery (HP:0001787) | 1.59474433 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA2 | 3.81421307 |
| 2 | TESK1 | 3.38056859 |
| 3 | LIMK1 | 3.27952064 |
| 4 | NME2 | 2.74966236 |
| 5 | MET | 2.72406503 |
| 6 | PBK | 2.60985800 |
| 7 | MST1R | 2.57953062 |
| 8 | MAP3K12 | 2.42719677 |
| 9 | ARAF | 2.42138230 |
| 10 | LATS2 | 2.31948639 |
| 11 | PTK2 | 2.25306543 |
| 12 | MYLK | 2.20297383 |
| 13 | NTRK1 | 2.13410006 |
| 14 | BUB1 | 2.10023421 |
| 15 | PDGFRA | 1.97862376 |
| 16 | LMTK2 | 1.95098942 |
| 17 | PAK4 | 1.83443691 |
| 18 | MAP3K9 | 1.79560314 |
| 19 | VRK2 | 1.73805677 |
| 20 | CAMK1D | 1.73549135 |
| 21 | TESK2 | 1.69187676 |
| 22 | MAP3K3 | 1.66245443 |
| 23 | PDK2 | 1.66155116 |
| 24 | ABL2 | 1.51482063 |
| 25 | RIPK1 | 1.50330629 |
| 26 | NEK1 | 1.48286017 |
| 27 | EPHB1 | 1.47303560 |
| 28 | MOS | 1.41410365 |
| 29 | PRKD3 | 1.40498140 |
| 30 | CAMK1G | 1.37299361 |
| 31 | DDR2 | 1.31292318 |
| 32 | EIF2AK1 | 1.24640015 |
| 33 | EPHB2 | 1.24352794 |
| 34 | ERBB4 | 1.22915227 |
| 35 | PNCK | 1.21766691 |
| 36 | ICK | 1.15768487 |
| 37 | WEE1 | 1.14801604 |
| 38 | ILK | 1.14463227 |
| 39 | FLT3 | 1.13581935 |
| 40 | BRSK1 | 1.13096285 |
| 41 | IRAK3 | 1.10432047 |
| 42 | NME1 | 1.09178395 |
| 43 | PAK6 | 1.07883069 |
| 44 | NEK9 | 1.04947624 |
| 45 | STK38 | 1.03831565 |
| 46 | PHKG1 | 1.01075373 |
| 47 | PHKG2 | 1.01075373 |
| 48 | TTN | 0.92007008 |
| 49 | EPHA4 | 0.90925349 |
| 50 | PIM2 | 0.90130933 |
| 51 | DAPK1 | 0.85702275 |
| 52 | PAK2 | 0.83772518 |
| 53 | TAOK2 | 0.81910581 |
| 54 | FER | 0.76733019 |
| 55 | CAMK2G | 0.75915928 |
| 56 | MAPKAPK3 | 0.73944791 |
| 57 | SMG1 | 0.73438982 |
| 58 | CAMKK2 | 0.72910376 |
| 59 | TRIB3 | 0.70867283 |
| 60 | PRKD2 | 0.68961413 |
| 61 | PAK1 | 0.67857292 |
| 62 | GRK5 | 0.66429071 |
| 63 | TSSK6 | 0.66059908 |
| 64 | STK16 | 0.65016638 |
| 65 | CSNK1G1 | 0.64482376 |
| 66 | LATS1 | 0.62572215 |
| 67 | LRRK2 | 0.62480119 |
| 68 | ROCK2 | 0.61351025 |
| 69 | CSNK1G3 | 0.61293236 |
| 70 | BRAF | 0.61152867 |
| 71 | SIK1 | 0.60747301 |
| 72 | AKT2 | 0.60468095 |
| 73 | DAPK3 | 0.59241439 |
| 74 | BMX | 0.58633687 |
| 75 | BCKDK | 0.56560306 |
| 76 | ERN1 | 0.52869042 |
| 77 | ROCK1 | 0.50000607 |
| 78 | MAP3K1 | 0.49950212 |
| 79 | AURKA | 0.49915691 |
| 80 | CSNK1A1L | 0.49495455 |
| 81 | CDK8 | 0.49236400 |
| 82 | PDGFRB | 0.45466666 |
| 83 | CDK7 | 0.45372635 |
| 84 | DMPK | 0.44066044 |
| 85 | SCYL2 | 0.43277254 |
| 86 | PRKG2 | 0.40705859 |
| 87 | GSK3A | 0.40069367 |
| 88 | TGFBR2 | 0.38189409 |
| 89 | INSRR | 0.36852703 |
| 90 | KSR2 | 0.36715980 |
| 91 | STK10 | 0.36250911 |
| 92 | MAP3K2 | 0.34198719 |
| 93 | TTK | 0.33756122 |
| 94 | MAP2K1 | 0.33489657 |
| 95 | CAMK2D | 0.33423701 |
| 96 | CAMK2B | 0.32808537 |
| 97 | MAP3K8 | 0.32005509 |
| 98 | MTOR | 0.28744200 |
| 99 | PTK2B | 0.28259694 |
| 100 | MAPKAPK5 | 0.25231869 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.97120883 |
| 2 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.81769072 |
| 3 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.69102871 |
| 4 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.32464793 |
| 5 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.31721612 |
| 6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.17818188 |
| 7 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.16033626 |
| 8 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.09118110 |
| 9 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 2.08616620 |
| 10 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.05734779 |
| 11 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.05521770 |
| 12 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.04830078 |
| 13 | Proteasome_Homo sapiens_hsa03050 | 2.00877865 |
| 14 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.00052099 |
| 15 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.90715806 |
| 16 | * Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.83100499 |
| 17 | Other glycan degradation_Homo sapiens_hsa00511 | 1.78717093 |
| 18 | Sulfur relay system_Homo sapiens_hsa04122 | 1.78057938 |
| 19 | Carbon metabolism_Homo sapiens_hsa01200 | 1.71752721 |
| 20 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.70238691 |
| 21 | * Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.57041930 |
| 22 | Galactose metabolism_Homo sapiens_hsa00052 | 1.53536303 |
| 23 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.48768763 |
| 24 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.44043668 |
| 25 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.43962378 |
| 26 | * Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.43436529 |
| 27 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.42900227 |
| 28 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.37403029 |
| 29 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.37193227 |
| 30 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.35029434 |
| 31 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.34701960 |
| 32 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.33474295 |
| 33 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.33471573 |
| 34 | * Glutathione metabolism_Homo sapiens_hsa00480 | 1.31249313 |
| 35 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.30639587 |
| 36 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.28818957 |
| 37 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.26702691 |
| 38 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.26418364 |
| 39 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.22503375 |
| 40 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.21927295 |
| 41 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.21643831 |
| 42 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.19765005 |
| 43 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.16781947 |
| 44 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.16461878 |
| 45 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.15998695 |
| 46 | Bile secretion_Homo sapiens_hsa04976 | 1.12461701 |
| 47 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.07911387 |
| 48 | Peroxisome_Homo sapiens_hsa04146 | 1.07385921 |
| 49 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.03625304 |
| 50 | Histidine metabolism_Homo sapiens_hsa00340 | 1.01332846 |
| 51 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.01160647 |
| 52 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.97828435 |
| 53 | Retinol metabolism_Homo sapiens_hsa00830 | 0.92589700 |
| 54 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.90802363 |
| 55 | Prion diseases_Homo sapiens_hsa05020 | 0.88897831 |
| 56 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.88324650 |
| 57 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.87974002 |
| 58 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.86492262 |
| 59 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.81693174 |
| 60 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.77988179 |
| 61 | Mineral absorption_Homo sapiens_hsa04978 | 0.77960837 |
| 62 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.76780752 |
| 63 | Lysine degradation_Homo sapiens_hsa00310 | 0.74288858 |
| 64 | Focal adhesion_Homo sapiens_hsa04510 | 0.71919754 |
| 65 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.71450808 |
| 66 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.66615996 |
| 67 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.63832363 |
| 68 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.63281008 |
| 69 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.60397992 |
| 70 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.59485484 |
| 71 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.59393910 |
| 72 | Metabolic pathways_Homo sapiens_hsa01100 | 0.59182221 |
| 73 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.57512564 |
| 74 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.56090473 |
| 75 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.55865368 |
| 76 | Lysosome_Homo sapiens_hsa04142 | 0.50010793 |
| 77 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.49092817 |
| 78 | Adherens junction_Homo sapiens_hsa04520 | 0.47683126 |
| 79 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.47607581 |
| 80 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.46783106 |
| 81 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.44914646 |
| 82 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.43896574 |
| 83 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.42689441 |
| 84 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.42037489 |
| 85 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.40717522 |
| 86 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.39694657 |
| 87 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.39669558 |
| 88 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.39630965 |
| 89 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.38814620 |
| 90 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.38601960 |
| 91 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.37939934 |
| 92 | Tight junction_Homo sapiens_hsa04530 | 0.33870853 |
| 93 | Circadian rhythm_Homo sapiens_hsa04710 | 0.32693249 |
| 94 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.30769162 |
| 95 | Base excision repair_Homo sapiens_hsa03410 | 0.26733636 |
| 96 | Bladder cancer_Homo sapiens_hsa05219 | 0.26617857 |
| 97 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.26023504 |
| 98 | Amoebiasis_Homo sapiens_hsa05146 | 0.24536540 |
| 99 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.24529116 |
| 100 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.20052161 |

